Apilimod

Unknown Manufacturer

Indications

Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

COMBINATION THERAPY WITH APILIMOD AND GLUTAMATERGIC AGENTS
EP 3755332 A1Applicant: AI THERAPEUTICS INCPriority: 2018
CN
EP
US
5 publications
APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER
EP 3954375 A1Applicant: AI THERAPEUTICS INCPriority: 2014
CN
EP
US
3 publications
Apilimod for use in the treatment of renal cancer
US 10206910 B2Applicant: LAM THERAPEUTICS INCPriority: 2014
CN
US
3 publications
Methods for treating cancer using apilimod
US 10350213 B2Applicant: AI THERAPEUTICS INCPriority: 2015
CN
US
2 publications
STABILIZED APILIMOD COMPOSITIONS AND USES THEREOF
US 2024277720 A1Applicant: ORPHAI THERAPEUTICS INCPriority: 2021
CN
US
2 publications
APILIMOD COMPOSITIONS AND METHODS OF USE
- EP 4753717 A1
  Applicant: ORPHAI THERAPEUTICS INCPriority: 2023
  EP
  WO
  2 publications
- US 2024024332 A1
  Applicant: AI THERAPEUTICS INCPriority: 2023
  US
  2 publications
Apilimod compositions and methods for using same
US 10179135 B2Applicant: LAM THERAPEUTICS INCPriority: 2015
US
2 publications
BIOMARKERS FOR TREATING CANCER WITH APILIMOD
CN 108495633 AApplicant: LAM THERAPEUTICS INCPriority: 2016
CN
Anti-viral compositions containing PIKfyve inhibitors and use thereof
US 10729694 B2Applicant: AI THERAPEUTICS INCPriority: 2016
US
APILIMOD COMPOSITIONS AND METHODS FOR USING SAME IN THE TREATMENT OF ALZHEIMER'S DISEASE
CN 110167559 AApplicant: AI THERAPEUTICS INCPriority: 2016
CN